· Periodic Report
Q3 revenue KRW 20.4 billion, loss of KRW 3.2 billion from main business
Gobiolab sold KRW 20.4 billion worth in Q3 and lost KRW 3.2 billion from its main business, versus a KRW 0.4 billion loss a year earlier.
348150 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Gobiolab sold KRW 20.4 billion worth in Q3 and lost KRW 3.2 billion from its main business, versus a KRW 0.4 billion loss a year earlier.
Get app alerts for new disclosures from KoBioLabs, Inc..